Jaime Moreno
Overview
Explore the profile of Jaime Moreno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
360
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Y, Pulford C, Diaz P, Perez-Sepulveda B, Duarte C, Predeus A, et al.
PLoS Negl Trop Dis
. 2025 Jan;
19(1):e0012801.
PMID: 39874387
Salmonella enterica serovar Typhimurium is a prevalent food-borne pathogen that is usually associated with gastroenteritis infection. S. Typhimurium is also a major cause of bloodstream infections in sub-Saharan Africa, and...
2.
Moreno J, Nielsen H, Winther O, Teufel F
Bioinformatics
. 2024 Nov;
40(12).
PMID: 39540738
Motivation: Protein subcellular location prediction is a widely explored task in bioinformatics because of its importance in proteomics research. We propose DeepLocPro, an extension to the popular method DeepLoc, tailored...
3.
Camacho-Moreno G, Duarte C, Perdomo M, Maldonado L, Palacios J, Rojas J, et al.
IJID Reg
. 2024 Oct;
13:100449.
PMID: 39430601
Objectives: Sentinel surveillance for bacterial pneumonia (SSBP) allows the monitoring of immunopreventable diseases. The results of the SSBP carried out at HOMI, Fundación Hospital pediátrico de la Misericordia, are presented....
4.
Guerrero P, Albarran V, Gonzalez-Merino C, Garcia de Quevedo C, Sotoca P, Chamorro J, et al.
Oncologist
. 2024 Oct;
30(2).
PMID: 39425911
Background: Immune checkpoint inhibitors (ICI) have changed the therapeutic landscape of many solid tumors. Modulation of the intestinal microbiota by antibiotics (Abx) has been suggested to impact on ICI outcomes....
5.
Albarran V, Guerrero P, Garcia de Quevedo C, Gonzalez C, Chamorro J, Rosero D, et al.
Cancer Immunol Immunother
. 2024 Aug;
73(10):186.
PMID: 39093378
Previous studies have suggested a negative impact of steroids on the efficacy of immune checkpoint inhibitors (ICI), but how this effect is modulated by the dosage and time of administration...
6.
Moreno J, Gluud L, Galsgaard E, Hvid H, Mazzoni G, Das V
PLoS One
. 2024 May;
19(5):e0302853.
PMID: 38768139
Background: Chronic Kidney Disease (CKD) and Metabolic dysfunction-associated steatohepatitis (MASH) are metabolic fibroinflammatory diseases. Combining single-cell (scRNAseq) and spatial transcriptomics (ST) could give unprecedented molecular disease understanding at single-cell resolution....
7.
Cherrez-Ojeda I, Bousquet J, Gimenez-Arnau A, Godse K, Krasowska D, Bartosinska J, et al.
J Allergy Clin Immunol Pract
. 2024 Apr;
12(6):1575-1583.e1.
PMID: 38604531
Background: Patient-reported outcome measures (PROMs) are validated and standardized tools that complement physician evaluations and guide treatment decisions. They are crucial for monitoring atopic dermatitis (AD) and chronic urticaria (CU)...
8.
Albarran V, San Roman M, Pozas J, Chamorro J, Rosero D, Guerrero P, et al.
Front Immunol
. 2024 Mar;
15:1352805.
PMID: 38550594
Adoptive cell therapy (ACT) comprises different strategies to enhance the activity of T lymphocytes and other effector cells that orchestrate the antitumor immune response, including chimeric antigen receptor (CAR) T-cell...
9.
Bernal J, Diaz P, Perez-Sepulveda B, Valencia-Guerrero M, Clavijo V, Weisner M, et al.
IJID Reg
. 2023 Nov;
9:80-87.
PMID: 38020187
Objectives: This study aimed to provide evidence of the domestic benefits of introducing an integrative genomic analysis from the One Health approach in the national surveillance of between 1997-2017 in...
10.
Guerrero P, Albarran V, San Roman M, Gonzalez-Merino C, Garcia de Quevedo C, Moreno J, et al.
Cancers (Basel)
. 2023 Nov;
15(21).
PMID: 37958416
Metastatic colorectal cancer (mCRC) with mutated BRAF exhibits distinct biological and molecular features that set it apart from other subtypes of CRC. Current standard treatment for these tumors involves a...